BRTX
HEALTHCAREBioRestorative Therapies Inc
$0.24-0.01 (-3.62%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BRTX Today?
No stock-specific AI insight has been generated for BRTX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.19$2.05
$0.24
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-1.58
Dividend Yield—
Dividend / Share—
ROE-3.2%
Profit Margin—
Debt / Equity—
Trading
Volume1.2M
Avg Volume (10D)—
Shares Outstanding25.5M
BRTX News
21 articles- PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 7, 2026
- BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease – Ortho Spine NewsOrtho Spine News·May 7, 2026
- BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc DiseaseYahoo Finance·May 7, 2026
- Geron (GERN) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 6, 2026
- BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical PlatformYahoo Finance·Apr 30, 2026
- Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom FishingYahoo Finance·Apr 27, 2026
- BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical PlatformYahoo Finance·Apr 21, 2026
- BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical PlatformYahoo Finance·Apr 7, 2026
- BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc DiseaseYahoo Finance·Mar 30, 2026
- Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue EstimatesYahoo Finance·Mar 26, 2026
- Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue EstimatesYahoo Finance·Mar 24, 2026
- Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag EstimatesYahoo Finance·Mar 19, 2026
- BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc DiseaseYahoo Finance·Mar 19, 2026
- Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue EstimatesYahoo Finance·Mar 17, 2026
- BC-Most Active StocksYahoo Finance·Mar 10, 2026
- BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026Yahoo Finance·Mar 5, 2026
- BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital StrategyYahoo Finance·Mar 4, 2026
- BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 DrugsYahoo Finance·Feb 24, 2026
- BioRestorative Announces Closing of $5.0 Million Public OfferingYahoo Finance·Feb 14, 2026
- BioRestorative Announces Pricing of $5.0 Million Public OfferingYahoo Finance·Feb 12, 2026
- BioRestorative Announces Positive Outcome from Type B Meeting with FDAYahoo Finance·Feb 11, 2026
All 21 articles loaded
Price Data
Open$0.25
Previous Close$0.25
Day High$0.26
Day Low$0.23
52 Week High$2.05
52 Week Low$0.19
52-Week Range
$0.19$2.05
$0.24
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-1.58
Dividend Yield—
Dividend / Share—
ROE-3.2%
Profit Margin—
Debt / Equity—
Trading
Volume1.2M
Avg Volume (10D)—
Shares Outstanding25.5M
About BioRestorative Therapies Inc
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols that primarily involve adult stem cells. The company is headquartered in Melville, New York.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—